 Connection
Kevin Ess to Tuberous Sclerosis
This is a "connection" page, showing publications Kevin Ess has written about Tuberous Sclerosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.938 |
|
|
|
-
Ess KC, Franz DN. Everolimus for cognition/autism in children with tuberous sclerosis complex: Definitive outcomes deferred. Neurology. 2019 07 09; 93(2):51-52.
Score: 0.606
-
Ess KC, Chugani HT. Dynamic tubers in tuberous sclerosis complex: A window for intervention? Neurology. 2015 Nov 03; 85(18):1530-1.
Score: 0.469
-
Carson RP, Fu C, Winzenburger P, Ess KC. Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. Hum Mol Genet. 2013 Jan 01; 22(1):140-52.
Score: 0.381
-
Ess KC, Roach ES. New therapies for tuber-less sclerosis: white matter matters? Neurology. 2012 Feb 21; 78(8):520-1.
Score: 0.363
-
Kim SH, Speirs CK, Solnica-Krezel L, Ess KC. Zebrafish model of tuberous sclerosis complex reveals cell-autonomous and non-cell-autonomous functions of mutant tuberin. Dis Model Mech. 2011 Mar; 4(2):255-67.
Score: 0.333
-
Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol. 2010 Apr; 23(2):189-93.
Score: 0.320
-
Ess KC. The neurobiology of tuberous sclerosis complex. Semin Pediatr Neurol. 2006 Mar; 13(1):37-42.
Score: 0.241
-
Ess KC, Kamp CA, Tu BP, Gutmann DH. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex. Neurology. 2005 Apr 26; 64(8):1446-9.
Score: 0.227
-
Chalkley ML, Guerin LN, Iyer T, Mallahan S, Nelson S, Sahin M, Hodges E, Ess KC, Ihrie RA. Human TSC2 mutant cells exhibit aberrations in early neurodevelopment accompanied by changes in the DNA Methylome. Hum Mol Genet. 2025 Apr 06; 34(8):684-698.
Score: 0.227
-
Arceneaux JS, Brockman AA, Khurana R, Chalkley ML, Geben LC, Krbanjevic A, Vestal M, Zafar M, Weatherspoon S, Mobley BC, Ess KC, Ihrie RA. Multiparameter quantitative analyses of diagnostic cells in brain tissues from tuberous sclerosis complex. Cytometry B Clin Cytom. 2025 Jan; 108(1):35-54.
Score: 0.215
-
Brown JA, Faley SL, Judge M, Ward P, Ihrie RA, Carson R, Armstrong L, Sahin M, Wikswo JP, Ess KC, Neely MD. Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit. J Neurodev Disord. 2024 May 23; 16(1):27.
Score: 0.213
-
Ess KC, Uhlmann EJ, Li W, Li H, Declue JE, Crino PB, Gutmann DH. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology. Glia. 2004 Apr 01; 46(1):28-40.
Score: 0.211
-
Short B, Kozek L, Harmsen H, Zhang B, Wong M, Ess KC, Fu C, Naftel R, Pearson MM, Carson RP. Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex. Neurobiol Dis. 2019 09; 129:93-101.
Score: 0.150
-
Rushing GV, Brockman AA, Bollig MK, Leelatian N, Mobley BC, Irish JM, Ess KC, Fu C, Ihrie RA. Location-dependent maintenance of intrinsic susceptibility to mTORC1-driven tumorigenesis. Life Sci Alliance. 2019 04; 2(2).
Score: 0.149
-
Krueger DA, Capal JK, Curatolo P, Devinsky O, Ess K, Tzadok M, Koenig MK, Narayanan V, Ramos F, Jozwiak S, de Vries P, Jansen AC, Wong M, Mowat D, Lawson J, Bruns S, Franz DN. Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience. Eur J Paediatr Neurol. 2018 Nov; 22(6):1066-1073.
Score: 0.142
-
Armstrong LC, Westlake G, Snow JP, Cawthon B, Armour E, Bowman AB, Ess KC. Heterozygous loss of TSC2 alters p53 signaling and human stem cell reprogramming. Hum Mol Genet. 2017 12 01; 26(23):4629-4641.
Score: 0.136
-
Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA. Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference. Pediatr Neurol. 2016 07; 60:1-12.
Score: 0.121
-
Kelm ND, West KL, Carson RP, Gochberg DF, Ess KC, Does MD. Evaluation of diffusion kurtosis imaging in ex vivo hypomyelinated mouse brains. Neuroimage. 2016 Jan 01; 124(Pt A):612-626.
Score: 0.117
-
de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Hook D, King BH, Sahin M, Jansen A. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol. 2015 Jan; 52(1):25-35.
Score: 0.110
-
Carson RP, Van Nielen DL, Winzenburger PA, Ess KC. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis. 2012 Jan; 45(1):369-80.
Score: 0.088
-
Zeng LH, Ouyang Y, Gazit V, Cirrito JR, Jansen LA, Ess KC, Yamada KA, Wozniak DF, Holtzman DM, Gutmann DH, Wong M. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis. 2007 Nov; 28(2):184-96.
Score: 0.066
-
Wong M, Ess KC, Uhlmann EJ, Jansen LA, Li W, Crino PB, Mennerick S, Yamada KA, Gutmann DH. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol. 2003 Aug; 54(2):251-6.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|